Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (126)

1

Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings

enthalten in: AIDS (London, England) | 2021

von Apornpong, T. | Grinsztejn, B. | Hughes, M. | +23

2

Genotypic resistance profiles of HIV-2-infected patients from Cape Verde failing first-line antiretroviral therapy

enthalten in: AIDS (London, England) | 2020

von Moranguinho, I. | Borrego, P. | Gonçalves, F. | +4

3

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy

enthalten in: AIDS (London, England) | 2018

von Mwasakifwa, G. | Moore, C. | Carey, D. | +10

ErratumIn: AIDS. 2018 Mar 13;32(5):683. - PMID 29494430

4

Protease inhibitors and preterm delivery : another piece in the puzzle

enthalten in: AIDS (London, England) | 2018

von Favarato, G. | Townsend, C. | Bailey, H. | +4

5

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir

enthalten in: AIDS (London, England) | 2017

von Jose, S. | Nelson, M. | Phillips, A. | +8

6

HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance

enthalten in: AIDS (London, England) | 2016

von Vivithanaporn, P. | Asahchop, E. | Acharjee, S. | +2

7

Acute interstitial nephritis caused by lopinavir/ritonavir in a surgeon receiving antiretroviral postexposure prophylaxis

enthalten in: AIDS (London, England) | 2015

von Chughlay, M. | Njuguna, C. | Cohen, K. | +1

8

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine

enthalten in: AIDS (London, England) | 2014

von Mwafongo, A. | Nkanaunena, K. | Zheng, Y. | +9

9

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting

enthalten in: AIDS (London, England) | 2014

von Clumeck, N. | Mwamba, C. | Kabeya, K. | +9

10

Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy

enthalten in: AIDS (London, England) | 2013

von Martin, A. | Moore, C. | Mallon, P. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]